A clinical study to evaluate the effects of a fat cell targeted gel for body skin laxity

A clinical study to validate the laxity reduction effects of a dual-acting lipolytic/adipogenic gel

Registry ID

ISRCTN11066382

Source registry

ISRCTN

Status

No longer recruiting

Study type

INTERVENTIONAL

Sponsor

Adipeau Inc.

Enrollment

30

Start date

2026-02-13

Completion date

2026-08-14

Last update

2026-08-17

Conditions

• Skin and Connective Tissue Diseases

Summary

Healthy adults

Detailed description

Strength Gel (Adipeau Inc), a marketed topical cosmetic containing Kaempferia Parviflora Extract as an active ingredient, was applied by participants 2x per day in a thin layer to areas of skin laxity.

Interventions

• OTHER: Strength Gel (Adipeau Inc), a marketed topical cosmetic containing Kaempferia Parviflora Extract as an active ingredient, was applied by participants 2x per day in a thin layer to areas of skin laxity.

Inclusion criteria

Moderate to severe skin laxity on the legs and/or buttocks.

Exclusion criteria

Anticipated changes to body composition through new exercise regimens, weight loss or major lifestyle changes.

Locations

• , , Australia
• , , United States of America

Related clinical trials

• A clinical study to evaluate the safety and effect of PRA-523, an investigational drug, compared to a drug with no active ingredient for the treatment of itch caused by atopic dermatitis
• A clinical research study in adults with chronic hand eczema, atopic dermatitis or vitiligo, to evaluate the safety and tolerability of a topically applied product that consists of ceramic sub-millimeter scale particles that are intended to create microscopic pores in the skin
• Scratch Less Study
• Effects of polyphenols extracted from Moringa oleifera leaves to heal split-thickness skin graft donor site wounds
• Low-dose isotretinoin versus standard-dose isotretinoin to treat severe acne in young people – the Acne-ID study
• TAR-0520 gel in EGFR inhibitor-induced folliculitis

View on source registry